Peroxisomes in dermatology. Part II

Journal of Cutaneous Medicine and Surgery

Volumn 5, Issue 4, 2001, Pages 315-322

  Smith, Kathleen J ^a   Dipreta, Edward ^a   Skelton, Henry ^b  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b LABORATORY CORPORATION OF AMERICA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CYCLOOXYGENASE 2 INHIBITOR; IBUPROFEN; INDOMETACIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; TRANSCRIPTION FACTOR;

ACNE VULGARIS; AGING; CELL DIFFERENTIATION; CELL PROLIFERATION; DISORDERS OF PEROXISOMAL FUNCTIONS; GENETIC DISORDER; HUMAN; PEROXISOME; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FAMILY; REVIEW; SIGNAL TRANSDUCTION; SKIN MANIFESTATION; STEROID METABOLISM; WOUND HEALING;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AGING; DNA-BINDING PROTEINS; HIV-1; HUMANS; LIPID METABOLISM; OXIDATIVE STRESS; PEROXISOMAL DISORDERS; PEROXISOMES; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SIGNAL TRANSDUCTION; SKIN; SKIN DISEASES; STEROIDS; TRANSCRIPTION FACTORS; WOUND HEALING;

EID: 0034849668     PISSN: 12034754     EISSN: None     Source Type: Journal    
DOI: 10.1007/s102270000126     Document Type: Review

References (83)

1. The role of peroxisomes in aging
2. Mechanism of action of the nongenotoxic peroxisome proliferators: Role of the peroxisome proliferator-activator receptor alpha
3. Lipid metabolism in peroxisomes in relation to human disease
4. On the role of the peroxisome in cell differentiation carcinogenesis
5. Peroxisome proliferators and cellular signaling pathways: A review
6. On the role of the peroxisome in cell differentiation and carcinogenesis
7. On the role of the peroxisome in the metabolism of drugs and xenobiotics
8. Lipidic signaling and peroxisomal function
9. Omega-3 fatty acids and the peroxisome
10. The biological significance of plasmalogens in defense against oxidative damage
11. Medical significance of peroxisome proliferator actived receptors
12. The RXR heterodimers and orphan receptors
13. Relation of dehydroepiandrosterone and dehydroepiandrosterone sulfate with cardiovascular disease risk factors in women: Longitudinal results from the Massachusetts women's health study
14. Modulation of fatty acid signaling by cytochrome P450 mediated hydroxylation
15. Oxidant antioxidants and the degenerative diseases of aging
16. Stimulation of the DNA binding activity of AP-1 by the peroxisome proliferator ciprofibrate and eicosanoids in cultured rat hepatocytes
17. Cross-talk between janus kinase signal transducer and activator of transcription (JAK-STAT) and peroxisome proliferator-activated receptor-alpha (PPAR alpha) signaling pathways. Growth hormone inhibition of par alpha transcriptional activity mediated by stat 5b
18. Inhibition of inducible nitric oxide synthase by peroxisome proliferator-activated receptor agonists: Correlation with induction of heme oxygenase 1
19. An update on the mechanisms of action of the peroxisome proliferator-activated (PPARs) and their roles in inflammation and cancer
20. Interleukin 4 dependent production of PPAR-gamma ligands in macrophages by 12/15-lipoxygenase
21. An update on the mechanisms of action of the peroxisome proliferator-activated receptors (PPARs) and their roles in inflammation and cancer
22. Peroxisome proliferator-activated receptor-alpha activators regulate genes governing lipoprotein metabolism, vascular inflammation and atherosclerosis
23. Peroxisome proliferator activated receptor activators target human endothelial cells to inhibit leukocyte endothelial cell interaction
24. Peroxisome proliferator activated receptors: Transcriptional regulators of adipogenesis, lipid metabolism and more
25. Role of metabolism in the activation of dehydroepiandrosterone as a peroxisome proliferator
26. Tissue-specific induction of 17β-hydroxysteroid dehydrogenase type IV by peroxisome proliferator chemicals is dependent on the peroxisome proliferator-activated receptor α
27. Mechanism of action of the nongenotoxic peroxisome proliferators: Role of the peroxisome proliferator acted receptor alpha
28. Mutations in the gene encoding 3 β-hydroxsteroid-Δ8,Δ7-isomerase cause X-linked dominant Conradi-Hunermann syndrome
29. Mutation in a Δ8,Δ7 sterol isomerase in the tattered mouse X-linked dominant chondrodysplasia punctata
30. RSH/Smith-Lemli-Opitz syndrome: Mutations metabolic morphogenesis
31. Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning
32. Current understanding of the molecular actions of vitamin D
33. Cholesterol modification of hedgehog signaling proteins in animal development
34. Cholesterol metabolism and embryogenesis
35. Simvastatin inhibits leukocyte-endothelial cell interactions and protects against inflammatory processes in normocholesterolemic rats
36. Peroxisome proliferator (PPAR) alpha-regulated growth responses and their importance to hepatocarcinogenesis
37. Regulation of keratinocyte growth differentiation in hyperproliferative epidermal PPAR alpha activator restores tissue hemostasis
38. Orphan nuclear receptors: Shifting endocrinology into reverse
39. Activation of gene transcription by prostacyclin analogues is mediated by the peroxisome proliferator-activated receptor (PPAR)
40. PPAR alpha-activation promotes epidermal keratinocyte differentiation in vivo
41. Keratinocyte differentiation is stimulated by activators of the nuclear hormone receptor PPAR alpha
42. Differential expression of peroxisome proliferator-activated receptor subtypes during the differentiation of human keratinocytes
43. Vitro evidence for involvement of CoA thioesters in peroxisome. In proliferation and hypolipidemia
44. Peroxisome proliferating sulphur-and oxy-substituted fatty acid analogues are activated to acyl coenzynne A thioester
45. Effects of omega-3 fatty acids on lipid metabolism
46. Dietary fat and carcinogenesis
47. Peroxisomal abnormality in fibroblasts from involved skin of CHILD syndrome
48. Unusual radiographic manifestations of chondrodysplasia punctata
49. Peroxisome proliferator-activated receptor α activation modulates cellular redox status, represses nuclear factor-β signaling, and reduces inflammatory cytokine production in aging
50. P450 gene induction by structurally diverse xenochemicals: Central role nuclear receptors CAR, PXR, PPAR
51. Linkage of the BH14 domain of Bcl-2 and nuclear factor kappa B. signaling pathway for suppression of apoptosis
52. Rat sebocyte differentiation involves peroxisome proliferator-activated receptors
53. Activation of the nuclear hormone receptors PPARα and FXR accelerate the development of the fetal epidermal permeability barrier
54. Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: Cohort study
55. Glucocorticoids repress induction by thiazolidinediones, fibrates, and fatty acids of phosphoenolpyruvate carboxykinase gene expression in adipocytes
56. Chemoprevention of spontaneous intestinal adenomas in the adenomatous polyposis coli in mouse model with aspirin
57. Prostaglandins promote block adipogenesis through opposing effects on peroxisome proliferator activated receptor gamma
58. Effects of acetylsalicylic acid on parameters related to peroxisome proliferation in mouse liver
59. Age-related changes in activation of mitogen-activated protein kinase cascades by oxidative stress
60. Inducible cyclooxygenase may have anti-inflammatory properties
61. The advent of highly selective inhibitors of cyclooxygenase - A review
62. New approaches to anti-inflammatory therapy for asthma
63. Carboxy-substituted cinnamides: A novel series of potent oral active LTB4 receptor antagonists
64. Reversing adipocyte differentiation: Implications for treatment of obesity
65. Novel peroxisome proliferator activated receptor PPAR gamma PPAR delta ligands produce distinct biological effects
66. Polyunsaturated fatty acids in the developing human brain, erythrocytes and plasma in peroxisomal disease: Therapeutic implications
67. 1,25-Dihydroxyvitamin D3 inhibits adipocyte differentiation and gene expression in murine bone marrow stromal cell clones and primary cultures
68. Vitamin A antagonizes the actions of vitamin D in rats
69. Opposite regulation of PPAR-alpha and -gamma gene expression by both their ligands and retinoic acid in brown adipocytes
70. 1,25 Dihydroxyvitamin D(3) and 9-cis-retinoic acid are synergistic regulators of 24-hydroxylase activity in the rat, and 1,25 dihydroxyvitamin D(3) alters retinoic acid metabolism in vivo
71. Retinoids and psoriasis: Retinoid pharmacology implications for psoriasis treatment
72. Molecular mechanisms of photoaging and its prevention by retinoic acid: Ultraviolet irradiation induces MMP kinase signal transduction cascades that induce AP-1-regulated matrix metalloproteinases that degrade human skin in vivo
73. Ligand for peroxisome proliferator activated receptor (troglitaxone) has potent antitumor effect against human prostate cancer both in vitro and in vivo
74. Ligands for peroxiome proliferator activated receptor gamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in BNX mice
75. Loss-of-function mutations in PPAR gamma associated with human colon cancer
76. Synergistic inhibition of prostate cancer cell lines by 19-nor hexafluoride, vitamin 3 analog, and antiactivator protein 1 retinoid
77. Novel 20-epi-vitamin D3 analog combined with 9-cis-retinoic acid markedly inhibits colony growth of prostate cancer cells
78. Mechanisms of androgen induction of sebocyte differentiation
79. The function of nitric oxide in wound repair: Inhibition of inducible nitric oxide synthase severely impairs wound reepithelialization
80. Minoxidil increases 17-beta-hydroxysteroid dehydrogenase and 5-alpha-reductase activity of cultured human dermal papilla cells from balding scalp
81. Clinical approach to inherited peroxisomal disorders: A series of 27 patients
82. Genetic peroxisomal disorder: Why, when and how to test
83. Plasma very long chain fatty acids, 3,000 peroxisome disease patients, and 29,000 controls